Skip to main content
. 2009 Feb 2;58(4):1028–1033. doi: 10.2337/db08-1179

FIG. 1.

FIG. 1.

Cumulative risk of development of persistent islet autoimmunity (calendar age) by PTPN22 genotypes (A) and cumulative risk of progression from persistent islet autoimmunity to type 1 diabetes (follow-up time since first islet autoimmunity positivity) by PTPN22 genotypes (B) were estimated by survival analyses.